Cibus to Participate in the BMO Global Farm to Market Conference

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic

GlobeNewswireMay 13 06:00

Earnings Call Summary | Cibus Inc(CBUS.US) Q1 2024 Earnings Conference

The following is a summary of the Cibus, Inc. (CBUS) Q1 2024 Earnings Call Transcript:Financial Performance:Cibus reported a net loss of $27 million for Q1 2024, increasing significantly from a net lo

Futu NewsMay 11 20:09 · Conference Call

HC Wainwright & Co. : The Cibus (CBUS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $25.00.

HC Wainwright & Co. : The Cibus (CBUS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $25.00.

Zhitong FinanceMay 10 13:40

HC Wainwright & Co. Reiterates Buy on Cibus, Maintains $25 Price Target

HC Wainwright & Co. analyst Amit Dayal reiterates Cibus (NASDAQ:CBUS) with a Buy and maintains $25 price target.

BenzingaMay 10 13:40

Cibus Q1 2024 GAAP EPS $(1.12) Up From $(5.46) YoY, Sales $545.000K Up From $42.000K YoY

Cibus (NASDAQ:CBUS) reported quarterly losses of $(1.12) per share. This is a 79.49 percent increase over losses of $(5.46) per share from the same period last year. The company reported $545.000 tho

BenzingaMay 9 17:20

Cibus (CBUS.US): The 2024 Q1 financial report achieved revenue of $545,000, the previous value was US$42,000, and the expected value was US$390,000; earnings per share were -1.12 US dollars, the previous value was -5.46 US dollars, and the expected value

Cibus (CBUS.US): The 2024 Q1 financial report achieved revenue of $545,000, the previous value was US$42,000, and the expected value was US$390,000; earnings per share were -1.12 US dollars, the previous value was -5.46 US dollars, and the expected value was -1.01 US dollars.

Zhitong FinanceMay 9 17:20